Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

3.
4.

The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers.

Seaber E, On N, Phillips S, Churchus R, Posner J, Rolan P.

Br J Clin Pharmacol. 1996 Feb;41(2):141-7.

6.

Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group.

Solomon GD, Cady RK, Klapper JA, Earl NL, Saper JR, Ramadan NM.

Neurology. 1997 Nov;49(5):1219-25.

PMID:
9371897
7.
8.

No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis.

Gillotin C, Bagnis C, Mamet JP, Peck RW, Deray G.

Int J Clin Pharmacol Ther. 1997 Nov;35(11):522-6.

PMID:
9401835
9.
10.
11.
12.
13.
14.

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, Poole PH.

Neurology. 2000 Jan 11;54(1):156-63.

PMID:
10636142
15.
16.

Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.

Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.

CNS Drugs. 2003;17(11):839-51.

PMID:
12921494
17.

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.

Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD.

Arch Neurol. 1996 Nov;53(11):1132-7.

PMID:
8912486
18.

Review of zolmitriptan and its clinical applications in migraine.

Dowson AJ, Charlesworth B.

Expert Opin Pharmacother. 2002 Jul;3(7):993-1005. Review.

PMID:
12083998
19.

Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.

Mauskop A, Farkkila M, Hering-Hanit R, Rapoport A, Warner J.

Curr Med Res Opin. 1999;15(4):282-9.

PMID:
10640260

Supplemental Content

Support Center